On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
ThursdayJun 21, 2018 3:04 pm

QualityStocksNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Takes Aim at Massive Alternative Medicines Market

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is pursuing therapies for a variety of physical ailments through nature-centric research. An article discussing the company reads: “PreveCeutical’s drive to develop its Nature Identical line of biopharmaceuticals positions it to take advantage of the mainstreaming of the complementary and alternative medicine market, a sector that’s expected to generate $196.87 billion in revenues by 2025, according to a report by Grand View Research, Inc. (http://ibn.fm/LN4EP). The market has been driven by the popularity of herbal dietary supplements and other wellness therapies like yoga and acupuncture, but the recent global clamor for…

Continue Reading

ThursdayJun 21, 2018 2:57 pm

QualityStocksNewsBreaks – AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) Prospers in Rapidly Increasing Big Data Industry

Artificial intelligence (“AI”) data delivery company AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is leveraging its technology in the big data industry that market analysts at Statista foresee reaching $84 billion level by 2024 (http://ibn.fm/l5VvQ). A recent article discussing the company reads, “While companies worldwide strive to build success and weather market uncertainties, AnalytixInsight has found appeal with those seeking a measure of security in the form of data-driven analysis on the competition, as well as the companies’ internal systems. … AnalytixInsight’s AI-based fintech platform CapitalCube is finding licensees among leading financial news agencies, web portals and stock exchanges. Amid the…

Continue Reading

ThursdayJun 21, 2018 11:45 am

QualityStocksNewsBreaks – Medical Cannabis Payment Solutions (REFG) Secures New Revenue Streams

Cannabis-focused financial services company Medical Cannabis Payment Solutions (OTC: REFG) is currently focusing its efforts on expanding within the cannabis industry. An article discussing the company reads: “Medical Cannabis Payment Solutions (OTC: REFG) is a state-of-the-art financial services company serving the medical cannabis and banking industries. The company brought to market the first and only comprehensive card processing operation of its kind. This innovative system tracks sales and tax collection, eliminates the need to deal in cash-only transactions, offers online enrollment and empowers businesses with an advanced client management system. Once focused solely on Green, its comprehensive financial program for…

Continue Reading

ThursdayJun 21, 2018 11:38 am

QualityStocksNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) to Serve Domesticated Animals via CBD-based Suite of Products

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) has a suite of CBD-based pet products in development, targeting indications such as inflammation, post-surgical pain and joint pain, as well as skin disorders. An article discussing the company reads: “Pivot recently announced that it was accelerating development of its CBD pet product line, which will be marketed under the name ‘Pivot Naturals For Pets’ (http://ibn.fm/qIBnJ). This product line will include capsules and sachets to deliver bio-available CBD, using Pivot’s proprietary and patented Ready-To-Infuse-Cannabis powder. In addition, the company is using its Thrudermic Transdermal Nanotechnology to develop and commercialize a series…

Continue Reading

WednesdayJun 20, 2018 2:52 pm

QualityStocksNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Provides Chinese Investors with Investment Education via Bitcoin Talk Show

Premier financial information company ChineseInvestors.com, Inc. (OTCQB: CIIX) recently announced the launch of a cryptocurrency and blockchain talk show titled “Bitcoin Talk Show.” An article discussing the company reads: “The 22-minute talk show has entered into a contract to air monthly for one year and broadcast to audiences in North America, as well as to be aired on the ChineseFN and Newcoins168.com YouTube channels. … The launch of Bitcoin Talk Show is only one key part of the company’s strategic plan to provide Chinese investors with essential cryptocurrency investment education and trading tools. CIIX provides real-time market commentary, analysis and…

Continue Reading

WednesdayJun 20, 2018 2:43 pm

QualityStocksNewsBreaks – Earth Science Tech, Inc. (ETST) Offers Diversity through Subsidiaries

Innovative biotech company Earth Science Tech (OTC: ETST) is focused on developing medical devices for the pharmaceutical and nutraceutical fields and marketing its high-grade line of hemp cannabidiol (“CBD”). The company also holds four distinct subsidiaries. An article discussing the company reads: “ETST holds four wholly owned subsidiaries. Cannabis Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures and distributes in the recreational sector. Earth Science Foundation, Inc. is becoming a non-profit to accept grants and donations for conducting additional studies. Earth Science Pharmaceutical develops medical diagnostic tools and vaccines.” To view the full article, visit http://ibn.fm/9R0AL About Earth Science Tech,…

Continue Reading

WednesdayJun 20, 2018 1:40 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Continues to Develop Potential Uses of Patented Technology

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed and is already licensing DehydraTECH™, a technology that improves the bio-absorption and bioavailability of ingestible substances. A recent article discussing the company’s unique technology reads: “Application of the technology extends beyond nicotine to non-psychoactive cannabinoids, vitamins and non-steroidal anti-inflammatory drugs (NSAIDs), and Lexaria has licensed the technology to a number of companies, including chocolate maker Nuka Enterprises; cannabis beverage manufacturer GP Holdings; and Biolog, which markets hemp-based, cannabidiol (CBD)-infused products and vitamins. Lexaria is expected to sign 6-12 more licensing agreements in 2018. These are typically six-figure contracts in the first…

Continue Reading

WednesdayJun 20, 2018 1:31 pm

QualityStocksNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Progresses in Hemp Cultivation

British Columbia-based hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is devoted to building a portfolio of hemp-focused businesses that aim to produce the ancient, versatile crop. An article discussing the company reads: “Global Hemp Group was founded in 2014 with Canadian headquarters in Vancouver, British Columbia, and additional base operations in Montreal and Los Angeles. Its hemp cultivation efforts are initially focused on the production of high quality sustainable raw materials and non-psychotropic cannabidiol (CBD) oil, as well as other cannabinoids, with no intoxicating effects. Global Hemp Group’s collaboration with other companies is an integral…

Continue Reading

MondayJun 18, 2018 9:31 am

QualityStocksNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Subsidiary Closes Okanagan Falls Property Purchase

Vertically integrated cannabis company Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) this morning announced that its wholly-owned subsidiary, Sunniva Medical Inc. ("SMI"), has closed the purchase of a 126-acre industrial zoned property in Okanagan Falls, BC. The Sunniva Canada Campus, a facility designed to be a 740,000 sq. ft. Good Manufacturing Practice ("cGMP") compliant greenhouse, will be located on the newly purchased property. The total consideration of $7 million for the purchase is comprised of a $3.5 million cash payment with the remainder paid through a vendor take back mortgage financing ("VTBMF").  The VTBMF is for a one-year term with an…

Continue Reading

FridayJun 15, 2018 3:09 pm

QualityStocksNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Positioned in Growing Markets with Novel Therapies and Groundbreaking Delivery Platform

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is positioned in rapidly-growing markets with innovative preventative therapies and a groundbreaking cannabidiol (“CBD”) drug delivery platform. An article discussing this reads, “Research has shown CBD to be non-psychoactive and to have anti-inflammatory, anti-anxiety and anti-emetic properties (http://ibn.fm/KnsIZ). Following nasal administration, the formulations gel rapidly with mucosal tissue to facilitate direct nose-to-brain delivery of cannabinoids. The gel substantially improves bioavailability and provides controlled cannabinoid release, staying in the nasal passages for up to seven days.” To view the full article, visit http://ibn.fm/XczQC About PreveCeutical Medical Inc. PreveCeutical is a health sciences…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.


Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered